title: Gender differences in the relationships among obesity, adiponectin and brachial artery distensibility in adolescents and young adults.
abstract: BACKGROUND
  Obesity-related cardiovascular diseases (CVDs) are a major cause of cardiovascular (CV) mortality. Obesity-related reduction in vascular protective adipose-derived proteins, such as adiponectin (APN), has an important role.
  
  
  METHODS
  We compared brachial artery distensibility (BrachD) with APN, the level of adiposity and other CV risk factors (CVRFs) in 431 post-pubertal subjects (mean 17.9 years). Gender differences in average values were examined by t-tests. Correlations among BrachD, obesity and other CVRFs were examined. Regression analysis was performed to determine whether APN provided an independent contribution to BrachD, while controlling for obesity and other CVRFs.
  
  
  RESULTS
  Male subjects had lower BrachD (5.72+/-1.37 vs 6.45+/-1.60% change per mm Hg, P<0.0001) and lower APN (10.50+/-4.65 vs 13.20+/-6.53; all P<0.04) than female subjects. BrachD correlated with APN (r=0.25, P< 0.0001). Both BrachD and APN correlated with measures of body size, including height, weight and body mass index (BMI). Both correlated with higher systolic blood pressure, glucose, insulin and lower high-density lipoprotein cholesterol (all P<0.01). In multivariate analysis, APN, gender, APN*gender and BMI z-score predicted BrachD (r(2)=0.305). On the basis of gender difference, only BMI z-score was significant for male subjects (r(2)=0.080), whereas APN and BMI z-score contributed for female subjects (r(2)=0.242, all P<0.0001).
  
  
  CONCLUSIONS
  BrachD is independently influenced by obesity in both male and female subjects. In female subjects, APN exerts an additional independent effect even after adjusting for blood pressure (BP), lipid levels and insulin. Differences in the effect of the APN-adiposity relationship on obesity-related vascular disease may be one reason for gender differences in the development and progression of atherosclerosis.
authors.affiliation: Division of Preventive Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Elaine.Urbina@cchmc.org
authors.forename: E M
authors.initials: EM
authors.lastname: Urbina
authors.forename: P
authors.initials: P
authors.lastname: Khoury
authors.forename: L J
authors.initials: LJ
authors.lastname: Martin
authors.forename: D
authors.initials: D
authors.lastname: D'Alessio
authors.forename: L M
authors.initials: LM
authors.lastname: Dolan
mesh_terms: D052242:Adiponectin / Q000097:blood*; D050154:Adiposity / Q000502:physiology*; D000293:Adolescent; D050197:Atherosclerosis / Q000097:blood / Q000503:physiopathology; D001794:Blood Pressure / Q000502:physiology*; D001823:Body Composition; D015992:Body Mass Index; D001916:Brachial Artery / Q000378:metabolism / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008297:Male; D009765:Obesity / Q000097:blood / Q000150:complications / Q000503:physiopathology; D012307:Risk Factors; D012737:Sex Factors; D055815:Young Adult
chemical_list: D052242:Adiponectin
references.citation: Circulation. 2004 Jun 1;109(21):2595-604
references.pmid: 15173041
references.citation: Diabetologia. 2004 May;47(5):816-20
references.pmid: 15105989
references.citation: J Clin Endocrinol Metab. 2004 Feb;89(2):765-9
references.pmid: 14764794
references.citation: J Clin Endocrinol Metab. 2005 Aug;90(8):4615-21
references.pmid: 15886241
references.citation: J Am Soc Hypertens. 2007 Jun;1(3):200-207
references.pmid: 18431458
references.citation: Circulation. 1999 Dec 21-28;100(25):2473-6
references.pmid: 10604883
references.citation: Circulation. 2005 Feb 15;111(6):747-53
references.pmid: 15699257
references.citation: Circulation. 2001 Feb 27;103(8):1057-63
references.pmid: 11222466
references.citation: Am J Cardiol. 1997 Aug 1;80(3):323-30
references.pmid: 9264426
references.citation: J Clin Endocrinol Metab. 2005 Jul;90(7):4170-6
references.pmid: 15827100
references.citation: Diabetes. 2002 Oct;51(10):2968-74
references.pmid: 12351435
references.citation: J Clin Endocrinol Metab. 2008 Jan;93(1):131-8
references.pmid: 17925335
references.citation: J Clin Endocrinol Metab. 2005 Jul;90(7):4255-9
references.pmid: 15870125
references.citation: Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
references.pmid: 15286277
references.citation: Am J Hypertens. 2005 Jun;18(6):767-71
references.pmid: 15925733
references.citation: J Clin Endocrinol Metab. 2003 Jul;88(7):3236-40
references.pmid: 12843170
references.citation: Diabetes Care. 2004 Feb;27(2):308-13
references.pmid: 14747205
references.citation: J Biol Chem. 2002 Oct 4;277(40):37487-91
references.pmid: 12138120
references.citation: J Clin Endocrinol Metab. 2003 Nov;88(11):5375-80
references.pmid: 14602776
references.citation: Curr Vasc Pharmacol. 2003 Jun;1(2):107-9
references.pmid: 15320837
references.citation: Int J Obes Relat Metab Disord. 2000 Jul;24(7):861-8
references.pmid: 10918532
references.citation: J Clin Endocrinol Metab. 2007 May;92(5):1857-62
references.pmid: 17284625
references.citation: J Clin Endocrinol Metab. 2006 Jan;91(1):332-5
references.pmid: 16249291
references.citation: Metabolism. 2006 May;55(5):587-92
references.pmid: 16631433
references.citation: J Clin Invest. 1998 Sep 15;102(6):1083-91
references.pmid: 9739042
references.citation: Can J Cardiol. 2006 Feb;22 Suppl B:12B-17B
references.pmid: 16498507
references.citation: Circulation. 2005 Sep 20;112(12):1789-97
references.pmid: 16172286
references.citation: Am J Hypertens. 2003 May;16(5 Pt 1):350-5
references.pmid: 12745195
references.citation: J Card Fail. 2004 Feb;10(1):36-42
references.pmid: 14966773
references.citation: Hypertension. 2000 Feb;35(2):637-42
references.pmid: 10679510
references.citation: Mol Endocrinol. 2007 Feb;21(2):388-400
references.pmid: 17158222
references.citation: Am J Cardiol. 2002 Apr 15;89(8):946-51
references.pmid: 11950433
references.citation: Am J Hypertens. 2005 Dec;18(12 Pt 1):1543-8
references.pmid: 16364823
references.citation: Echocardiography. 2006 Nov;23(10):835-42
references.pmid: 17069601
references.citation: J Hum Hypertens. 2002 Jul;16(7):509-16
references.pmid: 12080436
references.citation: J Pediatr. 2005 Jun;146(6):751-8
references.pmid: 15973311
references.citation: Blood Press Monit. 1998 Apr;3(2):121-124
references.pmid: 10212341
references.citation: Am J Hypertens. 2005 Jan;18(1):30-5
references.pmid: 15691614
references.citation: J Clin Endocrinol Metab. 2005 Aug;90(8):4792-6
references.pmid: 15928248
references.citation: Thromb Res. 2003 Jun 15;110(5-6):365-9
references.pmid: 14592564
references.citation: Atherosclerosis. 2004 Sep;176(1):157-64
references.pmid: 15306189
references.citation: Hypertension. 2008 Jan;51(1):8-14
references.pmid: 17998473
references.citation: Histochem Cell Biol. 2005 Jan;123(1):75-87
references.pmid: 15616845
references.citation: Perit Dial Int. 2005 Jul-Aug;25(4):357-61
references.pmid: 16022092
references.citation: J Clin Endocrinol Metab. 2001 Sep;86(9):4321-5
references.pmid: 11549668
references.citation: Diabetes Care. 2003 Aug;26(8):2383-8
references.pmid: 12882866
references.citation: Obes Res. 2003 Aug;11(8):1018-26
references.pmid: 12917508
references.citation: J Hypertens. 2005 Oct;23(10):1839-46
references.pmid: 16148607
references.citation: Am J Hypertens. 2003 Jan;16(1):76-9
references.pmid: 12517688
references.citation: Horm Metab Res. 2000 Feb;32(2):47-50
references.pmid: 10741683
references.citation: Diabetes Care. 2004 Mar;27(3):739-45
references.pmid: 14988295
references.citation: N Engl J Med. 2002 Mar 14;346(11):802-10
references.pmid: 11893791
references.citation: Mol Cell Biochem. 2007 Aug;302(1-2):43-9
references.pmid: 17318406
references.citation: Lancet. 2001 Oct 27;358(9291):1400-4
references.pmid: 11705484
references.citation: J Am Coll Cardiol. 2006 Sep 19;48(6):1155-62
references.pmid: 16978998
references.citation: J Clin Endocrinol Metab. 2002 Oct;87(10):4652-6
references.pmid: 12364452
references.citation: Clin Cardiol. 2002 Apr;25(4):167-72
references.pmid: 12000074